Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation. / Hughes, D.; Pink, J.; Pirmohamed, M. et al.
Yn: Clinical Pharmacology and Therapeutics, 23.09.2013.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Hughes, D, Pink, J, Pirmohamed, M, Lane, S & Hughes, DA 2013, 'Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation', Clinical Pharmacology and Therapeutics. https://doi.org/10.1038/clpt.2013.190

APA

Hughes, D., Pink, J., Pirmohamed, M., Lane, S., & Hughes, D. A. (2013). Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation. Clinical Pharmacology and Therapeutics. https://doi.org/10.1038/clpt.2013.190

CBE

Hughes D, Pink J, Pirmohamed M, Lane S, Hughes DA. 2013. Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation. Clinical Pharmacology and Therapeutics. https://doi.org/10.1038/clpt.2013.190

MLA

Hughes, D. et al. "Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation". Clinical Pharmacology and Therapeutics. 2013. https://doi.org/10.1038/clpt.2013.190

VancouverVancouver

Hughes D, Pink J, Pirmohamed M, Lane S, Hughes DA. Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation. Clinical Pharmacology and Therapeutics. 2013 Medi 23. doi: 10.1038/clpt.2013.190

Author

Hughes, D. ; Pink, J. ; Pirmohamed, M. et al. / Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation. Yn: Clinical Pharmacology and Therapeutics. 2013.

RIS

TY - JOUR

T1 - Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation

AU - Hughes, D.

AU - Pink, J.

AU - Pirmohamed, M.

AU - Lane, S.

AU - Hughes, D.A.

PY - 2013/9/23

Y1 - 2013/9/23

U2 - 10.1038/clpt.2013.190

DO - 10.1038/clpt.2013.190

M3 - Article

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

ER -